Factores implicados en el desarrollo de vasoplejía tras cirugía cardiaca con circulación extracorpórea. Estudio prospectivo observacional

Alfirevic, 2011, Transfusion increases the risk for vasoplegia after cardiac operations, Ann Thorac Surg, 92, 812, 10.1016/j.athoracsur.2011.04.020 Papadopoulos, 2010, Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study, J Cardiothorac Surg, 5, 17, 10.1186/1749-8090-5-17 Riha, 2011, Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery, J Cardiothorac Vasc Anesth, 25, 736, 10.1053/j.jvca.2011.04.005 Tatoulis, 2006, Patterns of postoperative systemic vascular resistance in a randomized trial of conventional on-pump versus off-pump coronary artery bypass graft surgery, Ann Thorac Surg, 82, 1436, 10.1016/j.athoracsur.2006.04.053 Levin, 2009, Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome, Circulation, 120, 1664, 10.1161/CIRCULATIONAHA.108.814533 Weis, 2006, Association between vasopressor dependence and early outcome in patients after cardiac surgery, Anaesthesia, 61, 938, 10.1111/j.1365-2044.2006.04779.x Mekontso-Dessap, 2001, Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function, Ann Thorac Surg, 71, 1428, 10.1016/S0003-4975(01)02486-9 Byrne, 2004, Risk factors and outcomes for ‘vasoplegia syndrome’ following cardiac transplantation, Eur J Cardiothorac Surg, 25, 327, 10.1016/j.ejcts.2003.11.032 Lehot, 2012, Syndrome vasoplegique après chirurgie cardiaque sous circulation extra-corporelle, Ann Fr Anesth Reanim, 31, S18, 10.1016/S0750-7658(12)70049-7 Shanmugam, 2005, Vasoplegic syndrome--The role of methylene blue, Eur J Cardiothorac Surg, 28, 705, 10.1016/j.ejcts.2005.07.011 Ozal, 2005, Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery, Ann Thorac Surg, 79, 1615, 10.1016/j.athoracsur.2004.10.038 Noto, 2009, A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery, Interact Cardiovasc Thorac Surg, 9, 588, 10.1510/icvts.2009.209890 Laffey, 2002, The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist, Anesthesiology, 97, 215, 10.1097/00000542-200207000-00030 Sun, 2011, Is vasoplegic syndrome more prevalent with open-heart procedures compared with isolated on-pump CABG surgery, Cardiovasc Revasc Med, 12, 203, 10.1016/j.carrev.2010.10.004 Oh, 2006, Effects of chronic angiotensin ii receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass, Br J Anaesth, 97, 792, 10.1093/bja/ael268 Comfere, 2005, Angiotensin system inhibitors in a general surgical population, Anesth Analg, 100, 636, 10.1213/01.ANE.0000146521.68059.A1 Fischer, 2010, Vasoplegia during cardiac surgery: Current concepts and management, Semin Thorac Cardiovasc Surg, 22, 140, 10.1053/j.semtcvs.2010.09.007 Kunstyr, 2008, A retrospective analysis of Terlipressin infusion in patients with refractory hypotension after cardiac surgery, J Cardiovasc Surg (Torino), 49, 381